ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
1.550
+0.040 (2.65%)
Jul 3, 2026, 4:15 PM CET
ExpreS2ion Biotech Holding AB Employees
ExpreS2ion Biotech Holding AB had 19 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
19
Change
n/a
Growth
n/a
Revenue / Employee
848.32K SEK
Profits / Employee
-1.91M SEK
Market Cap
5.47M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 19 | 0 | - | 19 | 0 |
| Dec 31, 2025 | 19 | 1 | 5.56% | 19 | 0 |
| Dec 31, 2024 | 18 | -3 | -14.29% | 18 | 0 |
| Dec 31, 2023 | 21 | -8 | -27.59% | 21 | 0 |
| Dec 31, 2022 | 29 | 1 | 3.57% | 26 | 3 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 150 |
| 2cureX AB | 14 |
| Guard Therapeutics International AB | 12 |
| Fluicell AB | 11 |
| AcouSort AB | 11 |
| Alzinova AB | 7 |
| NanoEcho AB | 5 |
| Aptahem AB | 3 |
ExpreS2ion Biotech Holding AB News
- 5 weeks ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - ExpreS2ion Biotech Holding AB Quarterly report: Q1 2026 - Filings
- 5 weeks ago - ExpreS2ion Biotech Holding AB Slides: Q1 2026 - Filings
- 4 months ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - ExpreS2ion Biotech Holding AB Quarterly report: Q4 2025 - Filings
- 4 months ago - ExpreS2ion Biotech Holding AB Slides: Q4 2025 - Filings
- 4 months ago - ExpreS2ion Biotech Holding AB Annual report: Q4 2025 - Filings
- 8 months ago - ExpreS2ion Biotech Holding AB Transcript: Life Science Summit 2025 - Transcripts